Apple has secured a victory in its ongoing legal battle with Masimo over patents related to the Apple Watch's blood oxygen feature. The International Trade Commission allowed Apple to resume selling Apple Watch models with the feature enabled in the US as it did not infringe Masimo's patents. Masimo argued that Apple’s redesign still fell within the scope of the existing exclusion order, challenging U.S. Customs and Border Protection’�s approval of the updated watches. Following these rulings, the full Commission decided not to review the Administrative Law Judge's finding of no infringement. In a statement to 9to5Mac, Apple thanked the ITC for its decision, stating that it is pleased to continue offering its redesigned Blood Oxygen feature to users in America.